Transition from low-grade endometrial stromal sarcoma to high-grade endometrial stromal sarcoma

International Journal of Gynecological Pathology

Volumn 29, Issue 4, 2010, Pages 374-377

  Ohta, Yoshiki ^a   Suzuki, Takao ^b   Omatsu, Mutsuko ^a   Hamatani, Shigeharu ^a   Shiokawa, Akira ^a   Kushima, Miki ^c   Ota, Hidekazu ^a  

^a SHOWA UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^c SHOWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIUM SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SALPINGOOOPHORECTOMY; TUMOR DIFFERENTIATION; TUMOR GROWTH; ENDOMETRIAL NEOPLASMS; FATALITY; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

ADULT; ENDOMETRIAL NEOPLASMS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SARCOMA, ENDOMETRIAL STROMAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954113249     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181cef14b     Document Type: Article

References (10)

1. Chang KL, Crabtree GS, Lim-Tan SK, et al. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990;14:415-38.
2. Silverberg SG, Kurman RJ. Endometrial stromal tumors. In: Silverberg SG, Kurman RJ, eds. Atlas of Tumor Pathology. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease, Series III, Vol 2. Washington, DC: Armed Forces Institute of Pathology; 1992:91-112.
3. Hendrickson MR, Tavassoli FA, Kempson RL, et al. Mesenchymal tumours and related lesions. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumour. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003:233-44.
4. Kurihara S, Oda Y, Ohishi Y, et al. Endometrial stromal sarcomas and related high-grade sarcomas: immunohisto- chemical and molecular genetic study of 31 cases. Am J Surg Pathol 2008;32:1228-38.
5. D'Angelo E, Spagnoli LG, Prat J. Comparative clinicopatho-logic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system. Human Pathol 2009;40:1571-85.
6. Amant F, Woestenborghs H, Vandenbroucke V, et al. Transition of endometrial stromal sarcoma into high-grade sarcoma. Gynecol Oncol 2006;103:1137-40.
7. Cheung AN, Ng WF, Chung LP, et al. Mixed low grade and high grade endometrial stromal sarcoma of uterus: differences on immunohistochemistry and chromosome in situ hybridization. J Clin Pathol 1996;49:604-7.
8. Allred DC, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11:155-68.
9. Blom R, Malmström H, Guerrieri C. Endometrial stromal sarcoma of the uterus: a clinicopathologic, DNA flow cyto-metric, p53, and MDM-2 analysis of 17 cases. Int J Gynecol Cancer 1999;9:98-104.
10. Moinfar F, Gogg-Kamerer M, Sommersacher A, et al. Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1): potential basis for a new therapeutic approach. Am J Surg Pathol 2005;29:485-9.